Several Form I-9 errors that were previously considered "technical" violations have been reclassified as "substantive" violations, for which employers may be fined.
In a move with potentially significant implications for employers' approaches to drug testing, reasonable accommodation under the ADA and other workplace policies, the Department of Justice recently issued an order that reclassifies certain medical marijuana products as Schedule III controlled substances.